ELI LILLY & Co — Director's Dealing 2019

Feb 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2019-02-16

Reporting Person: Norton Johna (Senior VP, Global Quality)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-16	Common Stock	M	48	—	Acquired	82	Indirect
2019-02-16	Common Stock	F	17	$122.48	Disposed	65	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-16	Restricted Stock Unit	$	M	48	Disposed	2020-02-16	Common Stock (48.0)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20819	Direct
Common Stock	489	Indirect
Common Stock	2544	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: The Restricted Stock Units vest in three installments, 48 on February 16, 2018; 48 on February 16, 2019; and 97 on February 16, 2020.